Trade Summary

2 days ago, Manning Anthony M., serving as Dir at Monte Rosa Therapeutics, Inc. (GLUE), sold 10,000 shares at $23.11 per share, for a total transaction value of $231,100.00.

This sale represents a 100.00% decrease in Manning Anthony M.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 29, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 30, 2026 at 4:05 PM ET, 1 day after the trade was made.

Monte Rosa Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.